К содержанию
Dr. Tara EinullaevaMedical oncologist

Cancer glossary

CA 19-9 blood test: what a high level means and when it fails

CA 19-9 is a tumor marker for pancreatic, bile duct and stomach cancer. Why it rises when bile flow is blocked, and who does not produce it at all.

Written and medically reviewed by

Dr. Tara Einullaeva

Medical oncologist, 9 years in practice. Credentials · reviewed 17 October 2026

In short

CA 19-9 is a carbohydrate antigen whose blood level is often raised in cancers of the pancreas, gallbladder and bile ducts, and stomach. It is used to check whether treatment is working, not to look for cancer.

How it appears in your report

The lab report says “CA 19-9 — … U/mL” (or kU/L) with a reference range. Medical notes may say “CA 19-9 falling” or “CA 19-9 rising” — a comparison with earlier values. It helps to look at bilirubin alongside it: if bilirubin is high, the marker is read differently.

What it means

Reference point What to know
Upper limit usually 35–37 kU/L Depends on the test kit — check your report
Lewis (a-b-) in 5–10% of people The marker is not produced, so the test is uninformative

A rise without cancer can come from acute and chronic pancreatitis, cholecystitis, gallstones, cirrhosis, hepatitis and blocked bile flow of any cause. With obstructive jaundice, when a tumor or a stone blocks the bile duct, CA 19-9 can be high largely because of the blockage itself. The Association for Clinical Biochemistry states plainly that CA 19-9 should not be used as a screening test, alone or together with other markers.

Does it affect treatment

If the marker was raised before treatment, its trend helps show whether therapy is working: the MSD Manual notes this is its main use in advanced pancreatic cancer. But a change of treatment is decided on everything together: CT, how you feel and the marker. With jaundice, the numbers are read with caution and with bilirubin in mind. The final decision is your treating doctor’s. More about marker trends in the article on tumor markers. If your result raises questions, I can go through it in a consultation.

Questions to ask your doctor

  • Was my CA 19-9 raised before treatment, and can it be used to follow my disease?
  • Could the result be raised because of bile flow problems? What is my bilirubin?
  • How often should I have the test, and at which lab?

Sources

  1. CA 19-9 (carbohydrate antigen 19-9): Lab Tests Guideline — Association for Clinical Biochemistry and Laboratory Medicine, 2012
  2. Tumor Marker Tests in Common Use — National Cancer Institute, 2023
  3. Tumor Immunodiagnosis — MSD Manual Professional Version

FAQ

Related terms

This is reference information and not a substitute for medical advice. Your doctor interprets each value in the context of your whole situation.

Related articles

All blog articles